Céline Verheust

487 total citations
8 papers, 340 citations indexed

About

Céline Verheust is a scholar working on Molecular Biology, Infectious Diseases and Ecology. According to data from OpenAlex, Céline Verheust has authored 8 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Ecology. Recurrent topics in Céline Verheust's work include Bacteriophages and microbial interactions (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Bacillus and Francisella bacterial research (2 papers). Céline Verheust is often cited by papers focused on Bacteriophages and microbial interactions (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Bacillus and Francisella bacterial research (2 papers). Céline Verheust collaborates with scholars based in Belgium, United States and Sweden. Céline Verheust's co-authors include Jacques Mahillon, Katia Pauwels, Gert B. Jensen, Didier Breyer, Martine Goossens, Philippe Herman, Nadine Fornelos, Donald R. Helinski, Rik Gijsbers and Jaan Toelen and has published in prestigious journals such as Journal of Bacteriology, Microbiology and Vaccine.

In The Last Decade

Céline Verheust

8 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Verheust Belgium 6 207 142 116 61 56 8 340
Robert L. Bull United States 11 269 1.3× 77 0.5× 104 0.9× 65 1.1× 26 0.5× 14 395
Erica A. Birkholz United States 9 277 1.3× 216 1.5× 78 0.7× 43 0.7× 48 0.9× 10 406
Catherine D. Jepson United Kingdom 9 155 0.7× 220 1.5× 59 0.5× 50 0.8× 76 1.4× 9 391
Z Ben‐Ishai Israel 9 119 0.6× 63 0.4× 64 0.6× 61 1.0× 69 1.2× 15 295
Kathleen Wilke Germany 7 416 2.0× 138 1.0× 154 1.3× 37 0.6× 28 0.5× 8 570
Anne‐Marie Andersson Denmark 11 261 1.3× 62 0.4× 60 0.5× 106 1.7× 92 1.6× 19 448
Indulis Cielēns Latvia 11 265 1.3× 262 1.8× 58 0.5× 112 1.8× 119 2.1× 16 578
Regīna Renhofa Latvia 10 189 0.9× 180 1.3× 33 0.3× 121 2.0× 107 1.9× 13 456
Milko Kermekchiev United States 13 530 2.6× 125 0.9× 106 0.9× 58 1.0× 29 0.5× 17 674
Lukas Rajkowitsch Austria 11 762 3.7× 138 1.0× 265 2.3× 62 1.0× 29 0.5× 12 860

Countries citing papers authored by Céline Verheust

Since Specialization
Citations

This map shows the geographic impact of Céline Verheust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Verheust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Verheust more than expected).

Fields of papers citing papers by Céline Verheust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Verheust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Verheust. The network helps show where Céline Verheust may publish in the future.

Co-authorship network of co-authors of Céline Verheust

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Verheust. A scholar is included among the top collaborators of Céline Verheust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Verheust. Céline Verheust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Verheust, Céline, et al.. (2020). Safety profile of Infanrix hexa – 17 years of GSK’s passive post-marketing surveillance. Expert Review of Vaccines. 19(8). 771–779. 4 indexed citations
2.
Verheust, Céline, Martine Goossens, Katia Pauwels, & Didier Breyer. (2012). Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine. 30(16). 2623–2632. 81 indexed citations
3.
Verheust, Céline, Katia Pauwels, Jacques Mahillon, Donald R. Helinski, & Philippe Herman. (2010). Contained use of Bacteriophages: Risk Assessment and Biosafety Recommendations. Applied Biosafety. 15(1). 32–44. 39 indexed citations
4.
Pauwels, Kris, Philippe Herman, Céline Verheust, et al.. (2009). Risk assessment of laboratories involving the manipulation of unconventional agents causing TSE. Open Repository and Bibliography (University of Liège). 2 indexed citations
5.
Pauwels, Katia, Rik Gijsbers, Jaan Toelen, et al.. (2009). State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations. Current Gene Therapy. 9(6). 459–474. 89 indexed citations
6.
Verheust, Céline & Donald R. Helinski. (2007). The incC korB region of RK2 repositions a mini-RK2 replicon in Escherichia coli. Plasmid. 58(2). 195–204. 6 indexed citations
7.
Verheust, Céline, Nadine Fornelos, & Jacques Mahillon. (2005). GIL16, a New Gram-Positive Tectiviral Phage Related to theBacillus thuringiensisGIL01 and theBacillus cereuspBClin15 Elements. Journal of Bacteriology. 187(6). 1966–1973. 52 indexed citations
8.
Verheust, Céline, Gert B. Jensen, & Jacques Mahillon. (2003). pGIL01, a linear tectiviral plasmid prophage originating from Bacillus thuringiensis serovar israelensis. Microbiology. 149(8). 2083–2092. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026